VentriPoint Diagnostics (TSXV:VPT) Cyclically Adjusted PB Ratio: (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is VentriPoint Diagnostics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


VentriPoint Diagnostics  (TSXV:VPT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


VentriPoint Diagnostics Cyclically Adjusted PB Ratio Related Terms


VentriPoint Diagnostics Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Cyclically Adjusted PB Ratio Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSXV:VPT vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, VentriPoint Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Cyclically Adjusted PB Ratio falls into.



VentriPoint Diagnostics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

VentriPoint Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 is calculated as:

For example, VentriPoint Diagnostics's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book=Book Value per Share/CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.024/130.3661*130.3661
=-0.024

Current CPI (Dec. 2025) = 130.3661.

VentriPoint Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
201603 -0.025 101.054 -0.032
201606 -0.052 102.002 -0.066
201609 -0.070 101.765 -0.090
201612 -0.070 101.449 -0.090
201703 -0.070 102.634 -0.089
201706 -0.015 103.029 -0.019
201709 -0.003 103.345 -0.004
201712 -0.032 103.345 -0.040
201803 -0.022 105.004 -0.027
201806 -0.022 105.557 -0.027
201809 -0.003 105.636 -0.004
201812 -0.016 105.399 -0.020
201903 -0.026 106.979 -0.032
201906 -0.036 107.690 -0.044
201909 -0.039 107.611 -0.047
201912 -0.036 107.769 -0.044
202003 -0.040 107.927 -0.048
202006 -0.044 108.401 -0.053
202009 -0.032 108.164 -0.039
202012 -0.026 108.559 -0.031
202103 0.005 110.298 0.006
202106 0.016 111.720 0.019
202109 0.013 112.905 0.015
202112 0.054 113.774 0.062
202203 0.049 117.646 0.054
202206 0.041 120.806 0.044
202209 0.034 120.648 0.037
202212 0.029 120.964 0.031
202303 0.022 122.702 0.023
202306 0.015 124.203 0.016
202309 0.008 125.230 0.008
202312 0.001 125.072 0.001
202403 -0.006 126.258 -0.006
202406 -0.013 127.522 -0.013
202409 -0.015 127.285 -0.015
202412 -0.018 127.364 -0.018
202503 -0.022 129.181 -0.022
202506 -0.024 129.892 -0.024
202509 -0.028 130.287 -0.028
202512 -0.024 130.366 -0.024

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


VentriPoint Diagnostics Business Description

Other Exchanges VPTDF:USA
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.